LGT Fund Management Co Ltd. Acquires 1,523 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• LGT Fund Management Co Ltd. increased its stake in Intuitive Surgical, Inc. by 98.9%, acquiring an additional 1,523 shares to hold a total of 3,063 shares valued at $1.66 million.
• Major institutional investors like Nuveen LLC and Goldman Sachs have significantly increased their positions, showing strong institutional interest in the company.
• Analyst ratings are generally positive, with 14 analysts giving a Buy rating and price targets ranging from $550 to $615, indicating a bullish outlook for the stock.

LGT Fund Management Co Ltd. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 98.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,063 shares of the medical equipment provider's stock after purchasing an additional 1,523 shares during the quarter. LGT Fund Management Co Ltd.'s holdings in Intuitive Surgical were worth $1,664,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of ISRG. Nuveen LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth approximately $1,715,899,000. Goldman Sachs Group Inc. raised its position in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after purchasing an additional 584,375 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock valued at $1,680,922,000 after buying an additional 566,979 shares during the last quarter. Wellington Management Group LLP raised its position in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after buying an additional 453,335 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Wells Fargo & Company increased their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday, July 23rd. Evercore ISI raised their target price on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Finally, Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Saturday, September 27th. Fourteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $594.19.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the business's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company's stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 2.1%

NASDAQ:ISRG opened at $452.35 on Friday. The business's 50-day moving average price is $463.55 and its two-hundred day moving average price is $500.06. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market cap of $162.16 billion, a P/E ratio of 63.09, a PEG ratio of 4.74 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter last year, the firm posted $1.78 EPS. The company's revenue was up 21.4% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.